Immune-Mediated Therapies for Liver Cancer
Open Access
Abstract
In recent years, immunotherapy has gained renewed interest as an alternative therapeutic approach for solid tumors. Its premise is based on harnessing the power of the host immune system to destroy tumor cells. Development of immune-mediated therapies, such as vaccines, adoptive transfer of autologous immune cells, and stimulation of host immunity by targeting tumor-evasive mechanisms have advanced cancer immunotherapy. In addition, studies on innate immunity and mechanisms of immune evasion have enhanced our understanding on the immunology of liver cancer. Preclinical and clinical studies with immune-mediated therapies have shown potential benefits in patients with liver cancer. In this review, we summarize current knowledge and recent developments in tumor immunology by focusing on two main primary liver cancers: hepatocellular carcinoma and cholangiocarcinoma.Keywords
This publication has 143 references indexed in Scilit:
- A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus InfectionPLOS ONE, 2013
- Liver antigen-presenting cellsJournal of Hepatology, 2011
- Direct, Help-Independent Priming of CD81 T Cells by Adeno-Associated Virus-Transduced Hepatocytes†Hepatology, 2010
- The changing pattern of epidemiology in hepatocellular carcinomaDigestive and Liver Disease, 2010
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2Molecular Therapy, 2010
- Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activationHuman Immunology, 2009
- Poor allostimulatory function of liver plasmacytoid DC is associated with pro-apoptotic activity, dependent on regulatory T cellsJournal of Hepatology, 2008
- Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancerCancer Immunology, Immunotherapy, 2008
- Mechanism of T cell tolerance induction by murine hepatic Kupffer cellsHepatology, 2008
- Hepatocellular carcinoma pathogenesis: from genes to environmentNature Reviews Cancer, 2006